🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Core Scientific shares hold Buy rating

EditorAhmed Abdulazez Abdulkadir
Published 11/07/2024, 17:16
CORZ
-

On Thursday, H.C. Wainwright maintained a Buy rating on Core Scientific Inc. (NASDAQ: CORZ), with a price target of $15.00. The firm's analysis highlighted the recent machine deal between Core Scientific and Block-ePIC, noting the competitive landscape in the bitcoin mining hardware sector.

Despite numerous new entrants in the market, such as Auradine and Jihan Wu's Sealminer, Core Scientific is seen to be leveraging its partnership strategically.

The analyst pointed out the industry's attempts to capitalize on what seems to be an easily accessible opportunity, albeit one that requires some effort to reach.

Bitmain's success in previous bull cycles was mentioned, where the company benefited from inflated mining machine prices. However, the industry is now shifting focus towards a more holistic view of the mining machines.

Auradine's approach to incorporate greater intelligence into their machines was noted, enabling miners to optimize profitability by managing power costs against the bitcoin mining hash price. This innovation is something that a leading U.S. bitcoin miner plans to use to its advantage.

The deal, which came to the public's attention on Wednesday, is believed to have been in the works for some time. This speculation is based on Block's announcement of its 3nm chip production in late April, which was shared in a company blog post.

Additionally, ePIC Blockchain Technologies, based in Toronto, has been identified as the preferred original equipment manufacturer (OEM) for several independent miners, including two that are publicly traded, one in London and the other in Vancouver.

H.C. Wainwright's reaffirmed $15 price target and Buy rating for Core Scientific reflects confidence in the company's strategic partnerships and position within the evolving bitcoin mining industry. The firm's stance remains unchanged in light of the recent developments and the competitive dynamics of the market.

In other recent news, Core Scientific Inc. has maintained its Buy rating from H.C. Wainwright, reflecting a positive outlook on the company's performance. The company has recently secured high-performance computing (HPC) hosting contracts totaling 270 megawatts, projected to generate over $4.7 billion in revenue over the next 12 years.

Additionally, Core Scientific expanded its hosting agreement with CoreWeave, which is expected to generate an additional $1.225 billion in cumulative revenue.

In terms of infrastructure, Core Scientific has expanded its operational capacity to 832 MW following a 72 MW expansion at its Denton, Texas data center. The company has also announced a significant agreement with Block Inc. for the acquisition of advanced 3 nanometer mining ASICs, marking a major development in the bitcoin mining sector.

The company's CEO, Adam Sullivan, has also secured a new employment agreement that includes a base salary of $625,000 and an annual incentive target of 125% of the base salary, contingent upon performance criteria.

InvestingPro Insights

In light of H.C. Wainwright's optimistic outlook on Core Scientific Inc. (NASDAQ: CORZ), it's worth considering additional insights provided by InvestingPro. Core Scientific's market capitalization stands at a robust $1.74 billion, reflecting investor confidence in the company's market position. Despite a slight revenue decline of 1.3% in the last twelve months as of Q1 2023, the company has shown a substantial quarterly revenue growth of 48.6% in Q1 2023, indicating a potential turnaround and resilience in its business model.

InvestingPro Tips suggest that Core Scientific's net income is expected to grow this year, which could justify the high P/E ratio of 74.93. Additionally, analysts predict the company will be profitable this year, aligning with H.C. Wainwright's positive rating. With a strong return of 225.67% over the last three months, investors have already witnessed significant gains, and the company's high shareholder yield could further incentivize investment.

For those interested in a deeper analysis, there are additional InvestingPro Tips available that can shed more light on Core Scientific's financial health and market prospects. Readers looking to explore these insights can use the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription, providing access to a comprehensive set of tools and data for informed investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.